ArticleJBMR plus2025

Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density.

Timo Damm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.